Skip to main content

EPM Application Market 2023 Forecast

Technavio logo
image: technavio.com
A former Mitchell & Co. Outstanding CEO honoree, John Klein serves as chairman of Cambridge Therapeutics, which he founded in 2011 to deliver combination drug therapies. Concurrently, John Klein is the chairman and CEO of the Alpine, NJ-based Bilogix, LLC, through which he provides enterprise performance management (EPM) solutions to business clients to better inform their decision-making processes and improve operational performance.

According to Technavio, the EPM application market is expected to grow by more than $2 billion by 2023, which equates to a compound annual growth rate of nearly 9 percent. Technavio has been monitoring the global market since 2015 and presented its findings in its recent 132-page market analysis report.

The report states that market growth will be driven by demand for cloud-based EPM solutions in addition to companies seeking to satisfy changing regulations. Given the volume and sensitive nature of data transferred across various industries, government bodies are increasingly approving new regulations concerning data collection, storage, and utilization.

Banking, financial services, and insurance companies are expected to generate the most revenue for EPM providers, while telecom and IT ranks second. Growth is also expected in manufacturing and healthcare. Moreover, the report projects the Asia-Pacific region as having the brightest outlook for the EPM market.
Labels:

Comments

Post a Comment

Popular posts from this blog

Bilogix Implements Enterprise Performance Management Solutions

The chairman of Alpine, New Jersey-based Cambridge Therapeutics, John Klein offers next-generation solutions in areas ranging from combination therapies to drug delivery. Building on his experience with Cambridge Therapeutics, John Klein recently launched Bilogix in Alpine, NJ, a provider of enterprise performance management (EPM) consulting services. Encompassing processes and applications, the EPM approach is one that transforms key performance indicator (KPI) data into highly accurate ways of analyzing, monitoring, measuring, and forecasting organizational results. It adds value through bringing focus on the details of how strategic plans are envisioned and implemented, as well as how challenges and inconsistencies are addressed when they occur. This ensures that resources are utilized more efficiently toward defined goals, at both the operational and tactical levels. At the same time, the effects of business intelligence investments can be tracked via a dashboard and r...
Post a Comment
Read more

New Jersey Aims to Ensure That All Children Have Health Insurance

John Klein has led Teaneck, New Jersey-based Cambridge Therapeutics since founding the pharmaceutical products manufacturer nearly a decade ago. He and his company provide a range of customer-friendly medical packaging options designed to increase patient adherence to prescription regimens. In addition to his role with Cambridge Therapeutics, John Klein is a board member with Hackensack Meridian Health Hospitals and regularly studies emerging information in the healthcare field in his state. In order to care for the most vulnerable of its citizens, the state of New Jersey oversees NJFamilyCare , a publicly funded insurance program that offers free or affordable health insurance for individuals of all ages. The program entitles policy holders to obtain visits to physicians, dentists, mental health professionals, and vision care specialists, as well as hospital services. However, the research group New Jersey Policy Perspective noted that the number of children enrolled in NJFamilyCar...
Post a Comment
Read more

Dwight-Englewood Earns Designation as One of New Jersey’s Top Schools

Cambridge Therapeutics leader John Klein has been in the pharmaceutical industry for nearly 30 years. In addition to his professional commitments to healthcare, John Klein is interested in improving education in his home state of New Jersey, where he serves as a trustee of the private preparatory school Dwight-Englewood, also known as D-E. The Dwight-Englewood School teaches children from kindergarten through high school in an innovative setting that emphasizes academic excellence. Recently, the community website Niche.com ranked D-E third among the top 100 private and public schools at all grade levels in the state and second among state private schools only. It earned a grade rating of A+. Factors considered for the evaluation of New Jersey’s schools included not only academics, but also the racial and economic diversity of the student population, parent and student experiences, and teacher performance, along with a collection of smaller factors. Dwight-Englewood’s ranking in this...
Post a Comment
Read more